Ketorolac tromethamine and Atrial fibrillation/flutter - a phase IV clinical study of FDA data

Summary:

Atrial fibrillation/flutter is found among people who take Ketorolac tromethamine, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Ketorolac tromethamine and have Atrial fibrillation/flutter. It is created by eHealthMe based on reports of 4,215 people who have side effects when taking Ketorolac tromethamine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 27, 2022

4,215 people reported to have side effects when taking Ketorolac tromethamine.
Among them, 50 people (1.19%) have Atrial fibrillation/flutter.


What is Ketorolac tromethamine?

Ketorolac tromethamine has active ingredients of ketorolac tromethamine. It is often used in pain. eHealthMe is studying from 4,395 Ketorolac tromethamine users for its effectiveness, alternative drugs and more.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 3,616 drugs and 3,424 conditions by eHealthMe.

Number of Ketorolac tromethamine and Atrial fibrillation/flutter reports submitted per year:

Could Ketorolac tromethamine cause Atrial fibrillation/flutter?

Time on Ketorolac tromethamine when people have Atrial fibrillation/flutter *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Atrial fibrillation/flutter when taking Ketorolac tromethamine *:

  • female: 22.45 %
  • male: 77.55 %

Age of people who have Atrial fibrillation/flutter when taking Ketorolac tromethamine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.27 %
  • 40-49: 0.0 %
  • 50-59: 13.64 %
  • 60+: 84.09 %

Common drugs people take besides Ketorolac tromethamine *:

  1. Cephalexin: 25 people, 50.00%
  2. Prednisone: 24 people, 48.00%
  3. Aspirin: 24 people, 48.00%
  4. Amoxicillin: 23 people, 46.00%
  5. Zometa: 23 people, 46.00%
  6. Colace: 21 people, 42.00%
  7. Dexamethasone: 21 people, 42.00%
  8. Zithromax: 20 people, 40.00%
  9. Xanax: 20 people, 40.00%
  10. Percocet: 17 people, 34.00%

Common side effects people have besides Atrial fibrillation/flutter *:

  1. Stress And Anxiety: 34 people, 68.00%
  2. Depression: 28 people, 56.00%
  3. Injury: 28 people, 56.00%
  4. Visual Impairment: 23 people, 46.00%
  5. Dental Caries: 23 people, 46.00%
  6. Infection: 23 people, 46.00%
  7. Headache (pain in head): 23 people, 46.00%
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 23 people, 46.00%
  9. Fall: 23 people, 46.00%
  10. Pain In Jaw: 21 people, 42.00%

Common conditions people have *:

  1. Constipation: 12 people, 24.00%
  2. Multiple Myeloma (cancer of the plasma cells): 7 people, 14.00%
  3. Bipolar Disorder (mood disorder): 6 people, 12.00%
  4. Depression: 5 people, 10.00%
  5. Stress And Anxiety: 4 people, 8.00%
  6. Indigestion: 4 people, 8.00%
  7. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 6.00%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.00%
  9. Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 4.00%
  10. High Blood Cholesterol: 2 people, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ketorolac tromethamine and have Atrial fibrillation/flutter?

Check whether Atrial fibrillation/flutter is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Atrial fibrillation/flutter and when was it recovered:

Expand to all the drugs that have ingredients of ketorolac tromethamine:

Alternative drugs to, pros and cons of Ketorolac tromethamine:

Common Ketorolac tromethamine side effects:

Browse all side effects of Ketorolac tromethamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Atrial fibrillation/flutter treatments and more:

COVID vaccines that are related to Atrial fibrillation/flutter:

Common drugs associated with Atrial fibrillation/flutter:

All the drugs that are associated with Atrial fibrillation/flutter:

Common conditions associated with Atrial fibrillation/flutter:

All the conditions that are associated with Atrial fibrillation/flutter:

How the study uses the data?

The study uses data from the FDA. It is based on ketorolac tromethamine (the active ingredients of Ketorolac tromethamine) and Ketorolac tromethamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: